Market Research Logo

Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019

Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019

The global preclinical imaging market is estimated to grow at a CAGR of 6.0% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the preclinical imaging market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 8.2% in the next five years. Factors such as increased outsourcing of preclinical research activities to Asia-based CROs by big pharmaceutical and biotechnological companies, owing to low cost of research in these nations; and increased government funding for drug discovery and development activities in economically emerging counties are propelling the growth of the preclinical imaging market in Asia-Pacific region.

The growth of the global preclinical imaging market is driven by factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT; growing acceptance of preclinical imaging as a legitimate drug development tool; and rising volume of preclinical research. In addition, emerging markets offering lucrative growth and departure of major companies from preclinical imaging systems market are creating new growth opportunities for the preclinical imaging systems and reagents manufacturers. Nonetheless, declining NIH (National Institutes of Health) funding for life science research, high implementation cost of preclinical imaging devices, and high cost and data requirements for bringing new imaging technology are the key reasons hampering the growth of preclinical imaging market.

In this report, the preclinical imaging market has been segmented on the basis of modality (covering optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems), by type of reagents (including nuclear imaging reagents, optical imaging reagents, MRIcontrast agents, ultrasound contrast agents and CT contrast agents), and by region (North America, Europe, Asia Pacific, and Rest of the World). The optical imaging systems market is estimated to account for the largest share of the global preclinical imaging systems market in 2014. However, the nuclear imaging systems segment is expected to grow at the highest rate during the forecast period. Factors such as development of technologically advanced hybrid nuclear imaging systems such as PET/MRI and PET/SPECT/CT and rising adoption of these devices in the preclinical research are driving the grow of the preclinical nuclear imaging systems market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of 36.2% of the global preclinical imaging market in 2014, followed by Europe. The preclinical imaging market in North America is primarily driven by various factors high volume of preclinical research in this region, easy availability and accessibility of resources (such as radioactive tracers), and rising government funding for research and innovation in Canada.
However, declining funding budgets of the U.S. National Institutes of Health (NIH) for preclinical research studies and recent changes in the Canadian R&D tax credit program are negatively affecting the growth of preclinical imaging market in North America.

The global preclinical imaging market is highly fragmented and competitive with a large number of global and local manufacturers of preclinical imaging systems and reagents. As of 2013, the global preclinical imaging market was dominated by PerkinElmer, Inc. (U.S.) and Bruker Corporation (U.S.), which together accounted for ~45% share of the market. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the preclinical imaging market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis —industry analysis (industry trends, and Porter’s five force model), market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the preclinical imaging systems and reagents market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on preclinical imaging products offered by the top 10 players in the preclinical imaging market. The report analyzes the preclinical imaging market by modality and type of reagent across four geographies

Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, and new product launches in the preclinical imaging market

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various preclinical systems and reagents across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the preclinical systems and reagents market

Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the preclinical systems and reagents market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • LIMITATION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS & LIMITATIONS
      • ASSUMPTIONS
      • LIMITATIONS
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • ATTRACTIVE MARKET OPPORTUNITIES IN THE PRECLINICAL IMAGING MARKET
    • PRECLINICAL IMAGING REAGENTS MARKETS, BY REGION (2014)
    • GLOBAL PRECLINICAL IMAGING SYSTEMS, BY REGION (2014)
    • GLOBAL PRECLINICAL IMAGING SYSTEMS MARKET, BY MODALITY, (2014-2019)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • BY MODALITY
      • BY REAGENT
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
      • KEY STAKEHOLDERS
      • KEY INFLUENCERS
    • INDUSTRY TRENDS
      • RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF HYBRID PRECLINICAL IMAGING SYSTEMS
      • INCREASING GOVERNMENT FUNDING FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN EMERGING NATIONS
    • PORTER'S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • THREAT FROM SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
  • GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY
    • INTRODUCTION
      • Table PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2012-2019 ($MILLION)
      • Table PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • OPTICAL IMAGING SYSTEMS
      • Table GLOBAL OPTICAL IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table OPTICAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS
        • Table BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2014 ($MILLION)
      • STANDALONE FLUORESCENCE IMAGING SYSTEMS
        • Table STANDALONE FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2014 ($MILLION)
      • OPTICAL + X-RAY/OPTICAL + CT
        • Table OPTICAL + X-RAY/OPTICAL + CT IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2014 ($MILLION)
    • PRECLINICAL NUCLEAR IMAGING SYSTEMS
      • Table GLOBAL PRECLINICAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table PRECLINICAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • MICRO-PET SYSTEMS
        • Table GLOBAL MICRO-PET SYSTEMS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table MICRO-PET SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table STANDALONE PET SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PET/CT SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PET/MRI SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • MICRO-SPECT SYSTEMS
        • Table GLOBAL MICRO-SPECT SYSTEMS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table MICRO-SPECT SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table STANDALONE SPECT SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table SPECT/CT SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • TRIMODALITY (SPECT/PET/CT) SYSTEMS
    • MICRO-MRI
      • Table MICRO-MRI SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • MICRO-ULTRASOUND
      • Table MICRO-ULTRASOUND SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • MICRO-CT
      • Table MICRO-CT SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS
      • Table PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS
  • GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENTS
    • INTRODUCTION
      • Table GLOBAL PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL OPTICAL IMAGING REAGENTS
      • Table GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • BIOLUMINESCENT IMAGING REAGENTS
        • Table GLOBAL PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PRECLINICAL LUCIFERINS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PRECLINICAL PROLUCIFERINS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PRECLINICAL COELENTERAZINE MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table OTHER PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • FLUORESCENT IMAGING REAGENTS
        • Table GLOBAL PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PRECLINICAL GREEN FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PRECLINICAL RED FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table PRECLINICAL INFRARED DYES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table OTHER PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL NUCLEAR IMAGING REAGENTS
      • Table GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • PRECLINICAL PET TRACERS
        • Table GLOBAL PRECLINICAL PET TRACERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table FLUORINE-18-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table CARBON-11-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table COPPER-64-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table OTHER PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • PRECLINICAL SPECT PROBES
        • Table GLOBAL PRECLINICAL SPECT PROBES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table TECHNETIUM-99M-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table IODINE-131-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table GALLIUM-67-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table THALLIUM-201-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
        • Table OTHER PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL MRI CONTRAST AGENTS
      • Table GLOBAL PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS
        • Table GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • IRON-BASED PRECLINICAL MRI CONTRAST AGENTS
        • Table IRON-BASED PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS
        • Table MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL ULTRASOUND CONTRAST AGENTS
      • Table PRECLINICAL ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • PRECLINICAL CT CONTRAST AGENTS
      • Table GLOBAL PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • IODINE-BASED PRECLINICAL CT CONTRAST AGENTS
        • Table IODINE-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS
        • Table BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • GOLD NANOPARTICLES
        • Table GOLD NANOPARTICLES PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS
        • Table GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
  • GEOGRAPHIC ANALYSIS
    • INTRODUCTION
      • Table GLOBAL PRECLINICAL IMAGING SYSTEMS AND REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2012-2019 ($MILLION)
      • Table U.S.: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
    • EUROPE
      • Table EUROPE: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2012-2019 ($MILLION)
      • Table EUROPE: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table ROW: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2012-2019 ($MILLION)
      • Table ROW: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS: PRECLINICAL IMAGING MARKET, BY KEY PLAYER, 2013
    • COMPETITIVE SITUATION AND TRENDS
      • NEW PRODUCT LAUNCHES AND PRODUCT DEVELOPMENTS
        • Table TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT DEVELOPMENTS, 2012-2014
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2014
      • GEOGRAPHICAL EXPANSIONS
        • Table TOP 5 GEOGRAPHICAL EXPANSIONS, 2012-2014
      • MERGERS AND ACQUISITIONS
        • Table MERGERS AND ACQUISITIONS, 2012-2014
      • OTHER DEVELOPMENTS
        • Table TOP 5 OTHER DEVELOPMENTS, 2012-2014
  • COMPANY PROFILES
    • INTRODUCTION
    • PERKINELMER, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
      • SWOT ANALYSIS
    • BRUKER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
      • SWOT ANALYSIS
    • FUJIFILM VISUALSONICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
      • SWOT ANALYSIS
    • MEDISO LTD.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
      • SWOT ANALYSIS
    • TRIFOIL IMAGING
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
    • MR SOLUTIONS LTD.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
    • ASPECT IMAGING
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
    • BIOSPACE LAB S.A.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
    • LI-COR BIOSCIENCES
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
    • MILABS B.V.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • KEY DEVELOPMENTS (2012-2014)
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE*
    • COMPANY DEVELOPMENTS (2012-2014)
      • ASPECT IMAGING
      • BRUKER CORPORATION
      • LI-COR BIOSCIENCES
      • MEDISO LTD.
      • MILABS B.V.
      • PERKINELMER, INC.
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report